肝癌二期切除20例临床分析  

Clinical analysis of second stage resection for primary liver cancer

作　　者：王捷[1] 区庆嘉[1] 陈积圣[1] 邓美海[2] 李玺 周修静[1] 江容坚[1] 罗葆明[1] 蒋宁一[1] 陈亚进[1] 刘晓平[1] 刘超[1] 黎洪浩[1] 周经兴[1] 

机构地区：[1]中山医科大学孙逸仙纪念医院外科,广东广州510120 [2]中山医科大学第三附属医院外科,广东广州510630

出　　处：《癌症》2000年第2期159-161,共3页Chinese Journal of Cancer

摘　　要：目的 :探讨不能切除肝癌的二期切除合理治疗方法。方法 :自 1986年 1月至 1998年 1月间 ,收治 14 0例不能切除的原发性肝癌病例 ,经各种不同治疗后 2 0例获二期切除。结果 :本组二期切除率为 14 2 9%。术后 1年、3年、5年生存率分别为 95 0 %、63 5 %、3 2 9%。其中位生存期为 4 6 2 9个月。结论 :多种综合治疗方式与单一治疗方式进行预治疗的两组病例中 ,以前者获得较高的二期切除率 ( 2 4 14 % )与长期生存率 ( 5年生存率 4 7.10 % )。Objective: To evaluate the reasonable treatment method of second stage resection for unresectable primary liver cancer Method: 140 patients with unresectable primary liver cancer had been treated in our hospital since 1986 to 1998 After single or combination treatment, 20 cases were secondly resected. The difference of second stage resection rate, complication, and survival time were compared between two groups Results: The second stage resection rate in whole group was 14 29% Survival rate of 1, 3, and 5 years was 95 0%, 63 5%and 32 9%, respectively Conclusion: The combination treatment group, as compared to single treatment gnup,will result in better second stage reseetion rate (24 14%), and 5 years survival rate (47.10%)

关 键 词：原发性 二期切除术 肝肿瘤 

分 类 号：R735.7[医药卫生—肿瘤]